ad image

Drug Design

1 / 1
The Disruptive Impact of Structural Biology on Biopharmaceutical Innovation
Structural Biology

The Disruptive Impact of Structural Biology on Biopharmaceutical Innovation

David Alvaro, Ph.D.

Pharma's Almanac

PAO-25-30-13Mar 02, 2025
Quris
Option Agreement

Merck KGaA, Darmstadt, Germany, Enters Into Option Agreement With Quris on Its BioAI Platform for Clinical Safety Prediction

Quris

PR-M02-22-08Feb 09, 2022
Janssen, Iktos Collaborate on In Silico Drug Design
Drug Design

Janssen, Iktos Collaborate on In Silico Drug Design

Emilie Branch

Pharma's Almanac

PAO-M05-19-NI-022May 21, 2019
Computer-Aided Drug Design Leads to Real Candidate and New Biotech Startup
Drug Design

Computer-Aided Drug Design Leads to Real Candidate and New Biotech Startup

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-M01-19-NI-024Jan 30, 2019
1 / 1